pISSN 2508-6235 eISSN 2508-7576

Download original image
Fig. 1. Efficacy of incretin hormones—glycosylated hemoglobin (HbA1c) change from baseline. LR, liraglutide; SM, semaglutide; TZP, tirzepatide. LR 0.6 mg, 1.2 mg, and 1.8 mg (LEAD2 study66); LR 3.0 mg (SCALE study13); SM 0.5 mg and 1.0 mg (SUSTAIN 1 study67); SM 2.4 mg (STEP2 study12); TZP 5 mg, 10 mg, and 15 mg (SURPASS 1 study14).
J Obes Metab Syndr 2022;31:123~133 https://doi.org/10.7570/jomes22001
© JOMES